oleanolic acid has been researched along with Kidney Diseases in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| He, L; Yang, W | 1 |
| Yamawaki, K | 1 |
| An, N; Cai, S; Pei, J; Peng, J; Wang, D; Wang, W; Wu, M; Zhan, X | 1 |
| Cheng, N; Li, Y; Liu, J; Luo, J; Ren, D; Xin, H; Yang, J; Zhang, J; Zhang, X | 1 |
| Hu, Q; Ji, H; Lu, G; Wu, H; Yang, Z; Zhou, M | 1 |
| Ku, SK; Kwak, MK; Lee, JH; Lee, SH; Ryoo, IG; Song, MK | 1 |
| Chang, YS; Choi, BS; Chung, S; Hong, YA; Kim, EN; Kim, MY; Koh, ES; Lim, JH; Park, CW; Shin, SJ | 1 |
| Dai, Z; Dang, C; Guan, H; Hui, W; Kang, H; Lin, S; Liu, X; Ma, X; Wang, X | 1 |
| Jadhav, RB; Mundada, S; Patil, CR; Patil, PR; Singh, PK | 1 |
| Aleksunes, LM; Goedken, MJ; Klaassen, CD; Manautou, JE; Rockwell, CE; Thomale, J | 1 |
| Thomas, MC | 1 |
| Gupta, A; Khaira, A | 1 |
| Ali, S; McCullough, PA | 1 |
| Basu, MK; Lala, S; Mahato, SB; Maitra, A; Nandy, AK; Tyagi, R; Verma, AK | 1 |
| Abdel-Rahman, MM; Abdel-Zaher, AO; Hafez, MM; Omran, FM | 1 |
2 review(s) available for oleanolic acid and Kidney Diseases
| Article | Year |
|---|---|
[Challenges in kidney disease: therapeutic potential of bardoxolone methyl].
Topics: Humans; Kelch-Like ECH-Associated Protein 1; Kidney Diseases; NF-E2-Related Factor 2; Oleanolic Acid; Quality of Life | 2022 |
Cardiac and renal function in patients with type 2 diabetes who have chronic kidney disease: potential effects of bardoxolone methyl.
Topics: Animals; Antioxidants; Chronic Disease; Diabetes Mellitus, Type 2; Humans; Kidney Diseases; Kidney Function Tests; NF-E2-Related Factor 2; Oleanolic Acid; Oxidants | 2012 |
13 other study(ies) available for oleanolic acid and Kidney Diseases
| Article | Year |
|---|---|
The protective effect of hederagenin on renal fibrosis by targeting muscarinic acetylcholine receptor.
Topics: Cell Line; Fibrosis; Humans; Kidney; Kidney Diseases; Oleanolic Acid; Pilocarpine; Receptors, Muscarinic; Transforming Growth Factor beta | 2022 |
The Protective Effect of Ursolic Acid on Unilateral Ureteral Obstruction in Rats by Activating the Nrf2/HO-1 Antioxidant Signaling Pathway.
Topics: Animals; Antioxidants; Fibrosis; Heme Oxygenase (Decyclizing); Kidney Diseases; NF-E2-Related Factor 2; Oleanolic Acid; Rats; Signal Transduction; Ureteral Obstruction; Ursolic Acid | 2022 |
Saikosaponin B2 attenuates kidney fibrosis via inhibiting the Hedgehog Pathway.
Topics: Animals; Fibroblasts; Fibrosis; Hedgehog Proteins; HEK293 Cells; Humans; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; NF-kappa B; NIH 3T3 Cells; Oleanolic Acid; Rats; Saponins; Signal Transduction; Smoothened Receptor; Zinc Finger Protein Gli2 | 2020 |
Emodinol ameliorates urate nephropathy by regulating renal organic ion transporters and inhibiting immune inflammatory responses in rats.
Topics: Animals; Blood Urea Nitrogen; Hyperuricemia; Inflammasomes; Inflammation; Interleukin-1beta; Kidney; Kidney Diseases; Male; Myeloid Differentiation Factor 88; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oleanolic Acid; Rats; Rats, Sprague-Dawley; Signal Transduction; Uric Acid | 2017 |
Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Topics: Animals; Aristolochic Acids; Cell Line; Extracellular Matrix; Fibrosis; Gene Expression Regulation; Gene Knockdown Techniques; HEK293 Cells; Humans; Kelch-Like ECH-Associated Protein 1; Kidney Diseases; Male; Mesangial Cells; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oleanolic Acid; RNA, Small Interfering; Signal Transduction; Smad7 Protein; Transforming Growth Factor beta1; Ubiquitin-Protein Ligases | 2019 |
Delayed treatment with oleanolic acid attenuates tubulointerstitial fibrosis in chronic cyclosporine nephropathy through Nrf2/HO-1 signaling.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antioxidants; Apoptosis; Biomarkers; Cell Nucleus; Cyclosporine; Cytoskeletal Proteins; Fibrosis; Heme Oxygenase-1; Kelch-Like ECH-Associated Protein 1; Kidney Diseases; Kidney Function Tests; Kidney Tubules; Male; Malondialdehyde; Mice; Mice, Inbred ICR; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oleanolic Acid; Proto-Oncogene Proteins c-bcl-2; Signal Transduction | 2014 |
Saikosaponin-D reduces cisplatin-induced nephrotoxicity by repressing ROS-mediated activation of MAPK and NF-κB signalling pathways.
Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cell Line; Cell Survival; Cisplatin; Cytokines; Humans; Kidney Diseases; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Oleanolic Acid; Reactive Oxygen Species; RNA, Messenger; Saponins; Signal Transduction | 2015 |
Protective effect of oleanolic acid on gentamicin induced nephrotoxicity in rats.
Topics: Administration, Oral; Albumins; Animals; Creatinine; Gentamicins; Glomerular Filtration Rate; Kidney; Kidney Diseases; Male; Oleanolic Acid; Rats; Rats, Wistar; Urea; Viscum | 2010 |
Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blood Urea Nitrogen; Blotting, Western; Cisplatin; DNA Adducts; Gene Expression; Gene Expression Regulation; Imidazoles; Immunohistochemistry; In Situ Nick-End Labeling; Inflammation; Kidney; Kidney Diseases; Mice; Mice, Knockout; Necrosis; NF-E2-Related Factor 2; Nucleic Acid Amplification Techniques; Oleanolic Acid; Platinum; RNA, Messenger; Transcription Factors | 2010 |
Bardoxolone: augmenting the Yin in chronic kidney disease.
Topics: Chronic Disease; Clinical Trials, Phase II as Topic; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; NF-E2-Related Factor 2; Oleanolic Acid; Randomized Controlled Trials as Topic; Signal Transduction; Time Factors; Treatment Outcome; Yin-Yang | 2011 |
Bardoxolone methyl: a targeted antioxidant.
Topics: Animals; Antioxidants; Chronic Disease; Humans; Kidney Diseases; Oleanolic Acid | 2011 |
Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis.
Topics: Animals; Antiparasitic Agents; Blood Urea Nitrogen; Chemical and Drug Induced Liver Injury; Chemistry, Pharmaceutical; Creatinine; Cricetinae; Drug Carriers; Enzymes; Female; Gels; Glucosides; Kidney Diseases; Lactic Acid; Leishmania donovani; Leishmaniasis, Visceral; Light; Magnetic Resonance Spectroscopy; Male; Microscopy, Electron, Transmission; Microspheres; Oleanolic Acid; Particle Size; Pharmaceutic Aids; Plant Bark; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Scattering, Radiation; Spectroscopy, Fourier Transform Infrared; Terminalia; X-Ray Diffraction | 2005 |
Role of nitric oxide and reduced glutathione in the protective effects of aminoguanidine, gadolinium chloride and oleanolic acid against acetaminophen-induced hepatic and renal damage.
Topics: Acetaminophen; Administration, Oral; Alanine Transaminase; Alkaline Phosphatase; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Creatinine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gadolinium; Glutathione; Guanidines; Injections, Intramuscular; Kidney Diseases; Liver Diseases; Male; Nitric Oxide; Oleanolic Acid; Protective Agents; Rats; Rats, Wistar; Survival Analysis; Survival Rate | 2007 |